Mainz Biomed B.V.

NASDAQ:MYNZ

0.22 (USD) • At close November 7, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -26.296-26.387-11.69-0.587-0.957
Depreciation & Amortization 0.8660.380.070.060.053
Deferred Income Tax 0.0420000
Stock Based Compensation 4.0069.8246.4300
Change In Working Capital -0.0651.387-0.1390.0580.423
Accounts Receivables 0.016-0.2110.024-0.0990.34
Inventory -0.5-0.172-670.725-0.160
Accounts Payables 0.721,824.402670.7250.160
Other Working Capital -0.3-1,822.631-0.1630.1570.083
Other Non Cash Items -0.4930.0272.10800.064
Operating Cash Flow -21.939-14.77-3.22-0.469-0.416
Investing Activities:
Investments In Property Plant And Equipment -1.899-0.658-0.017-0.010
Acquisitions Net 001.2200
Purchases Of Investments 00000
Sales Maturities Of Investments 00000
Other Investing Activites -0.701.2200
Investing Cash Flow -1.899-0.6581.203-0.010
Financing Activities:
Debt Repayment -2.286-0.305-0.061-0.039-0.03
Common Stock Issued 6.39323.86610.42500
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities -0.9340.3830.2470.4360.454
Financing Cash Flow 14.22723.94310.6110.3970.424
Other Information:
Effect Of Forex Changes On Cash -0.46-0.1010.0120.001-0.033
Net Change In Cash -10.0718.4148.605-0.081-0.026
Cash At End Of Period 7.07117.1428.7280.1230.204